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Picking Up on Preservatives
New Biomarkers for Gauging Paraben Exposure
As scientists seek to characterize human exposures to chemicals, they
need more valid, accurate biomarkers—telltale molecular signatures
that indicate a particular exposure has occurred. A team from the
CDC has now provided the field with a new biomarker that could
help researchers document exposures to a class of antimicrobial
preservatives called parabens [EHP 114:1843–1846; Ye et al.].
Parabens are used in shampoos, cosmetics, moisturizers, medica-
tions, foods, and beverages. Concerns have arisen about the potential
human health risks associated with the widespread use of these weakly
estrogenic compounds, including
widely publicized speculation that
parabens in antiperspirants were
linked to breast cancer. Although
that theory was later refuted, fre-
quent and common human expo-
sure to parabens means that
research attention will continue to
focus on these chemicals.
Until now, the only biomarker
used for human paraben exposure
was p-hydroxybenzoic acid in
urine. But that metabolite is pro-
duced by the hydrolysis of all of
the various paraben compounds,
so it is nonspecific to individual
parabens, which vary widely in
estrogenic bioactivity.
The CDC team measured the presence of free and conjugated par-
ent parabens in urine to determine their suitability to be biomarkers of
human exposures. They analyzed the urinary concentrations of methyl,
ethyl, n-propyl, butyl (n- and iso-), and benzyl parabens in 100 human
adults with no known industrial exposure to the compounds. The
results appear to support the viability of those measures as biomarkers
of exposure. 
Methyl and n-propyl parabens, the parabens most commonly used
in cosmetics and foods, were found at the highest median concentra-
tions in almost all the samples—99% contained the former and 96%
the latter. The authors say this could result from the widespread use of
these compounds; from differences in the absorption, distribution,
metabolism, and excretion of the vari-
ous parabens; or from a combination
of both factors. Other parent com-
pounds, such as ethyl and butyl
paraben, appeared in more than half
of the samples. 
Regardless of the reason for such
high frequencies of detection, the
researchers say their results suggest that
urinary parabens and their conjugates
could be valid biomarkers of exposure
to these chemicals. The detection and
measurement methodologies used by
the CDC scientists could help investi-
gators as they seek to characterize the
potential health risks associated with
exposure to the individual paraben
compounds. –Ernie Hood
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Thyroid Alert
Low Iodine and Perchlorate Effects in Women
Perchlorate, an oxidizer in solid rocket fuel, is widely found in
groundwater, drinking water, milk, vegetables, fruit, grain, and for-
age crops. Large doses of perchlorate have been shown to inhibit
iodide uptake and reduce thyroid hormone production, which can
contribute to metabolic problems in adults and abnormal neuro-
development during gestation and infancy. Now, researchers at the
CDC show that U.S. women with low iodine intake may be at risk
for reduced thyroid function due to perchlorate exposure [EHP
114:1865–1871; Blount et al.]. 
The researchers examined 2,299 men and women, aged 12 and
older, who participated in the National Health and Nutrition
Examination Survey. Examining the relationship between urine per-
chlorate concentrations and blood levels of the thyroid hormones
thyroxine (T4) and thyroid-stimulating hormone (TSH), which stim-
ulates T4, they observed that perchlorate was a significant predictor
of thyroid hormone levels in women, but not in men. 
Upon seeing this sex-based difference, the authors then categorized
1,111 women into “sufficient” and “low” iodine groups using a thresh-
old of 100 µg/L urinary iodine, based on WHO recommendations.
They found a slight relationship between perchlorate concentrations
and TSH for the sufficient-iodine group, but a much stronger one for
perchlorate and both T4 and TSH in the low-iodine group. 
For the low-iodine group, higher perchlorate was associated with
lower serum T4 and higher TSH. This relationship was consistent with
what would be expected if perchlorate were inhibiting iodine uptake to
such an extent that it interfered with thyroid hormone production. At
the 50th percentile of urinary perchlorate (2.9 µg/L), the predicted
decrease in T4 was 1.06 µg/dL; at the 95th percentile (13 µg/L), the
predicted decrease in T4 was 1.64 µg/dL. Given that the normal range
of T4 for women is 5–12 µg/dL, these predicted reductions were signif-
icant and indicate that even small increases in perchlorate exposure
may inhibit the thyroid’s ability to absorb iodine. 
In the United States, 36% of women have urinary iodine levels
under 100 µg/L. In addition, the perchlorate doses seen to cause effects
in this study are well below the 24.5 ppb reference dose recommended
in 2005 by a National Academy of Sciences panel. The authors say that
another large study is needed to confirm these findings; they are plan-
ning that study. –Richard Dahl
Biomarkers roll on. Scientists may have discovered a new way to mea-
sure exposure to parabens, an ingredient in many toiletries and cosmetics.
One thing leads to another. Thyroid tissue, with thyroglobulin, a protein
used to produce T4, shown in orange. Perchlorate may interfere with
iodide uptake by the thyroid, leading to altered thyroid hormone synthesis.Adding Up to ADHD
Effects of Early Exposures
Many studies have documented health risks of
childhood exposures to lead and tobacco smoke.
Both exposures have been implicated in the
development of attention deficit/hyperactivity
disorder (ADHD) in children. A team of
researchers now confirms links between both
neurotoxicants and ADHD development
[EHP 114:1904–1909; Braun et al.].
ADHD, one of the most common childhood
disorders, may affect up to 8% of children, cost-
ing society an estimated $9.2 billion per year.
However, the mechanisms for the development
of the disorder are unclear. Previous research has
implicated prenatal tobacco smoke exposure in
its development, but the relative contribution of
this exposure remains uncertain, and to date
there have been no convincing studies linking
lead exposure with diagnosis of ADHD. 
The researchers analyzed data collected from
3,879 children participating in the National
Health and Nutrition Examination Survey. They assessed ADHD in
children aged 4–15 years based on parental reports of diagnosis by a
health professional and the use of medication for ADHD. They also
used parental reports to estimate children’s pre- and postnatal exposure
to tobacco smoke, and analyzed blood samples to
determine lead concentration. The research team
then used logistic regression analysis to identify
predictors of ADHD.
Children exposed prenatally to tobacco smoke
were 2.5 times more likely to develop ADHD
than unexposed children, and those with a blood
lead concentration greater than 2 µg/dL had were
4 times more likely than children with the lowest
blood lead concentrations. Girls exposed prenatal-
ly to tobacco smoke were 4.6 times more likely
than unexposed girls to develop ADHD, and
exposed boys were twice as likely as unexposed
boys. Based on these results, the researchers esti-
mated that about 1 in 3 cases of ADHD could be
attributed to either prenatal tobacco smoke expo-
sure or childhood lead exposure.
The team acknowledges several limitations to
this study, including recall bias and the inability
to adjust for certain potential confounders.
However, they note that their findings confirm
the previously observed association of prenatal
tobacco smoke exposure and ADHD as well as
concern about whether low-level childhood lead exposure also is
linked. This evidence reinforces the need for strengthened public
health efforts aimed at reducing the occurrence of these exposures.
–Tanya Tillett
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Unwelcome Guest
Airborne Staph in Homes
Staphylococcus aureus, one of the most prevalent causes
of infections of the blood, skin, soft tissue, and lower
respiratory tract, spreads through close contact with
contaminated people and surfaces. Although a few
studies hint that airborne transmission of the microbe
may be involved in hospital infections, no studies have
examined indoor levels of S. aureus outside of a hospi-
tal setting. The first study to monitor S. aureus
bioaerosols in residences shows that strains of the bac-
terium are common inhabitants of indoor and outdoor
air [EHP 114:1859–1864; Gandara et al.]. Moreover,
indoor strains are particularly resistant to commonly
prescribed antibiotics. 
During March, April, and May 2006, researchers cul-
tured S. aureus from bioaerosol samples collected at 24
one-story homes in El Paso, Texas. They treated the bac-
terial colonies with three common antibiotics—ampi-
cillin, penicillin, and cefaclor—to assess drug resistance. 
All the indoor samples contained airborne S. aureus,
as did nearly half of the outdoor samples. S. aureus levels inside the
homes averaged 15.39 colony-forming units (CFU) per m3 air, and
outdoor samples averaged 12.63 CFU per m3. About half the indoor
samples were resistant to ampicillin, 60% were resistant to penicillin,
and 13% were resistant to cefaclor. Samples of S. aureus collected
outside the homes proved more susceptible to antibiotic killing, with
34% resisting ampicillin, 42% resisting penicillin, and 14% resisting
cefaclor. In addition, about 14% of all S. aureus samples showed
multidrug resistance, meaning the sample withstood both cefaclor
and either penicillin or ampicillin. No other investigators have mea-
sured household levels of aerosolized S. aureus resistant to antibiotics,
so the results have no basis for comparison. 
The health consequences of living with S. aureus bioaerosols were
not assessed in this study. The researchers plan to evaluate health
risks associated with bacterial bioaerosols, such as whether elevated
levels of drug-resistant S. aureus in indoor air parallel increases in
community-acquired infections—that is, infections acquired outside
a hospital setting. 
The prevalence of drug-resistant S. aureus infections continues to
rise, and rather than being confined largely to hospitals, such infec-
tions are increasing in the community, particularly in children. These
new findings suggest that residential exposure to aerosolized S. aureus
and a possible link to community-acquired S. aureus infections
deserve further study. –Carol Potera
Exciting data. New findings shed light on
links between ADHD and early exposure to
lead or tobacco smoke.
Down in the west Texas town. A study in El Paso, Texas, shows evidence of antibiotic-
resistant Staphylococcus aureus within residences.